WebMar 26, 2024 · Ironwood Pharmaceuticals (NASDAQ: IRWD) is a GI healthcare company dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. We ... WebApr 10, 2024 · 3 analysts have issued 1-year price targets for Ironwood Pharmaceuticals' shares. Their IRWD share price forecasts range from $13.00 to $16.00. On average, they predict the company's share price to reach $14.67 in the next twelve months. This suggests a possible upside of 39.4% from the stock's current price.
Ironwood Pharmaceuticals Company Profile
WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … WebMar 9, 2024 · On Wednesday 03/08/2024 the closing price of the Ironwood Pharmaceuticals Inc (A) share was $10.74 on NAS. Compared to the opening price on Wednesday … how many calories in 100g of strawberry
Ironwood Pharmaceuticals - Funding, Financials, Valuation
WebIronwood Pharmaceuticals wants to make our careers website accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process, please reach out to our Talent Acquisition department at [email protected] This contact information is for accommodation requests only and … WebDec 23, 2024 · Ironwood Pharmaceuticals Posts Flat Q4 Adjusted Profit, Revenue Drops; Sets Fiscal 2024.. Transcript : Ironwood Pharmaceuticals, Inc., Q4 2024 Earnings Call, Feb 16, 2.. Analyst Recommendations on IRONWOOD PHARMACEUTICALS, INC. Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains E.. WebMar 22, 2024 · Our focus is on unlocking the full therapeutic potential of the NO-cGMP pathway to address a broad range of serious CNS diseases. We have the expertise, team and determination to bring innovative medicines forward for patients. how many calories in 16 oz sprite